Structural characterization of native HBV capsids and virions from human cells
人类细胞天然 HBV 衣壳和病毒颗粒的结构表征
基本信息
- 批准号:10736669
- 负责人:
- 金额:$ 72.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-14 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnimal ExperimentsAntiviral AgentsArginineBiologyC-terminalCapsidCapsid ProteinsCell Culture SystemCell Culture TechniquesCellsClassificationComplexCryoelectron MicroscopyCytosolDataDiseaseDouble Stranded DNA VirusElectron MicroscopeEmbryoEnsureEnvironmentEnzymesEscherichia coliExhibitsFutureGenomeHepatitis B TherapyHepatitis B VirusHumanHydrophobicityIn VitroInfectionKidneyKnowledgeLipidsLocationMammalian CellMedicalMembrane ProteinsMethodologyModelingMolecularMolecular ConformationMolecular StructureMolecular VirologyMutationN-terminalNucleic Acid BindingNucleic AcidsPathogenesisPhosphorylationPhysiologicalPolymerasePost-Translational Protein ProcessingProcessProtein DephosphorylationProteinsPublic HealthPublishingRNARNA-Directed DNA PolymeraseReactionResolutionReverse TranscriptionSignal TransductionSingle-Stranded DNAStructureSystemVaccinesViralViral Envelope ProteinsViral GenomeViral Reverse TranscriptionVirionVirus DiseasesVirus Replicationantiviral drug developmentdesignds-DNAeffective therapyhepatoma cellinsightmutantnovelnovel therapeuticsparticleprematurepreventprotein structurereconstitutionresponsestructural determinantstrafficking
项目摘要
PROJECT SUMMARY
Hepatitis B virus (HBV) infection is a global public health concern. Despite effective vaccines to prevent this
disease, current approved treatment rarely leads to a complete cure. There is an unmet medical need for
developing new therapeutics for HBV infection that can lead to a sustained response. Targeting HBV capsid
assembly process has become an emerging strategy for developing new antiviral treatment for HBV. However,
many efforts have been made by using different capsid protein (Cp) constructs expressed in Escherichia coli to
mimic or reconstitute native-like viral particles. Yet, these structures cannot correctly represent the native HBV
conformations due to the lacks of nucleic acid binding domain of the Cp, viral genome, and viral enzymes, all of
which are required for viral replication. Furthermore, the lack of post translational modifications of the Cp also
hampers the interpretation between observed Cp structures to the biomedical data obtained from the mammalian
cell culture system or experimental animals. To date there is no available high-resolution native HBV structures,
which is a major gap in knowledge of the HBV field.
In this proposal, we aim to use cryo-electron microscope (cryo-EM) to directly characterize the structures of
native HBV capsids and virions from human cells. In Aim 1, we will determine the high-resolution structures of
purified intracellular HBV capsids with different types of viral genome. We will address the key questions
concerning the structural dynamics of HBV capsids during genome maturation. We will also determine the
structure of the HBV reverse transcriptase (RT) and its location during reverse transcription to help understand
its mode of action (whether the RT is static or moves). In Aim 2, we will investigate the high-resolution structures
of secreted HBV virions. This aim will address the questions concerning how HBV capsids interact with the viral
envelop proteins. Finally, experimental findings from these two Aims will be integrated to elucidate capsid
dynamics during HBV replication and illuminate the molecular determinant(s) of HBV envelopment.
This proposal is expected to solve 4 types of intracellular HBV capsid structures (empty, RNA-filled, single-
stranded DNA-filled, and mature partially double-stranded DNA-filled capsids) and 3 secreted enveloped HBV
virion structures (empty, mature, and prematurely secreted virions) using cryo-EM to define the conformational
changes of the capsid during viral replication, particularly in the context of different viral genome forms and
interactions between the capsid and surface proteins. The methodology exploits appropriate mutations of Cp
and RT to ensure obtaining homogenous particles of the various types as described above, which can be further
computationally classified to minimize cross-contamination.
Understanding the native HBV structures will provide valuable new information for HBV biology and guide the
design of novel antiviral drugs in the future. The project is anticipated to impact fields ranging from HBV,
molecular virology, antiviral drug development, and macromolecular structure and function.
项目摘要
B型肝炎病毒(HBV)感染是一个全球性的公共卫生问题。尽管有有效的疫苗来预防这种情况,
然而,目前批准的治疗很少导致完全治愈。有一个未满足的医疗需求,
开发新的治疗HBV感染的药物,可以导致持续的反应。靶向HBV衣壳
组装过程已成为开发新的HBV抗病毒治疗的新兴策略。然而,在这方面,
通过使用在大肠杆菌中表达的不同衣壳蛋白(Cp)构建体,
模拟或重组天然样病毒颗粒。然而,这些结构不能正确地代表天然HBV
由于缺乏Cp的核酸结合结构域、病毒基因组和病毒酶,所有的
这是病毒复制所必需的。此外,缺少Cp的翻译后修饰也
阻碍了从哺乳动物中获得的生物医学数据与观察到的Cp结构之间的解释
细胞培养系统或实验动物。迄今为止,还没有可用的高分辨率天然HBV结构,
这是HBV领域知识的一个主要空白。
在这个建议中,我们的目标是使用冷冻电子显微镜(cryo-EM)直接表征的结构,
来自人细胞的天然HBV衣壳和病毒体。在目标1中,我们将确定
具有不同类型病毒基因组的纯化的细胞内HBV衣壳。我们将解决关键问题
关于HBV衣壳在基因组成熟过程中的结构动力学。我们还将确定
HBV逆转录酶(RT)的结构及其在逆转录过程中的位置,以帮助了解
其作用模式(RT是静态的还是移动的)。在目标2中,我们将研究高分辨率结构
分泌的HBV病毒体。这一目标将解决关于HBV衣壳如何与病毒相互作用的问题。
包膜蛋白质。最后,这两个目的的实验结果将被整合,以阐明衣壳蛋白
HBV复制过程中的动力学,并阐明HBV复制的分子决定因素。
这一提议有望解决4种类型的细胞内HBV衣壳结构(空的、RNA填充的、单-
双链DNA填充的和成熟的部分双链DNA填充的衣壳)和3个分泌的包膜HBV
病毒体结构(空的、成熟的和过早分泌的病毒体),使用cryo-EM确定构象
病毒复制过程中衣壳的变化,特别是在不同病毒基因组形式的背景下,
衣壳和表面蛋白之间的相互作用。该方法利用Cp的适当突变
和RT,以确保获得如上所述的各种类型的均匀颗粒,其可以进一步
通过计算进行分类,以尽量减少交叉污染。
了解天然HBV结构将为HBV生物学提供有价值的新信息,并指导HBV的治疗。
未来新型抗病毒药物的设计。该项目预计将影响包括乙型肝炎病毒,
分子病毒学、抗病毒药物开发以及大分子结构和功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Che-Yen Wang其他文献
Che-Yen Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Che-Yen Wang', 18)}}的其他基金
Dissecting Structural Details of Hepadnavirus Subviral Particles
剖析嗜肝DNA病毒亚病毒颗粒的结构细节
- 批准号:
10287141 - 财政年份:2021
- 资助金额:
$ 72.8万 - 项目类别:
Dissecting Structural Details of Hepadnavirus Subviral Particles
剖析嗜肝DNA病毒亚病毒颗粒的结构细节
- 批准号:
10407642 - 财政年份:2021
- 资助金额:
$ 72.8万 - 项目类别:
相似海外基金
Development of decellularized small-diameter arterial grafts and evaluation in large animal experiments
脱细胞小直径动脉移植物的研制及大动物实验评价
- 批准号:
21H03016 - 财政年份:2021
- 资助金额:
$ 72.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Developing and validating a computational model of the gut microbiota-mucosa interactions to replace and reduce animal experiments
开发和验证肠道微生物群-粘膜相互作用的计算模型,以取代和减少动物实验
- 批准号:
NC/R001707/1 - 财政年份:2018
- 资助金额:
$ 72.8万 - 项目类别:
Training Grant
Developing and validating a computational model of the gut microbiota-mucosa interactions to replace and reduce animal experiments
开发和验证肠道微生物群-粘膜相互作用的计算模型,以取代和减少动物实验
- 批准号:
2103295 - 财政年份:2018
- 资助金额:
$ 72.8万 - 项目类别:
Studentship
Research on the way of information transmission to gain social understanding of animal experiments
动物实验获得社会理解的信息传递方式研究
- 批准号:
16K07080 - 财政年份:2016
- 资助金额:
$ 72.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CDS&E: Modeling the Zebrafish Model Organism Toward Reducing, Refining, and Replacing Animal Experiments
CDS
- 批准号:
1505832 - 财政年份:2015
- 资助金额:
$ 72.8万 - 项目类别:
Standard Grant
Never replicate a successful experiment? Standardization, heterogenization and reproducibility in animal experiments
从未复制过成功的实验?
- 批准号:
283089959 - 财政年份:2015
- 资助金额:
$ 72.8万 - 项目类别:
Research Grants
Arrhythmogenic Drug Evaluation System by Simplified Animal Experiments
简化动物实验的致心律失常药物评价系统
- 批准号:
26350520 - 财政年份:2014
- 资助金额:
$ 72.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Promotion of the 4Rs in animal experiments by the development of a production process for polyclonal antibodies using a goldfish
开发金鱼多克隆抗体生产工艺,促进动物实验中的4R
- 批准号:
23650227 - 财政年份:2011
- 资助金额:
$ 72.8万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of microangiographic systems to visualize cerebular perforating artery in clinical settings and retrobulbar ophthalmic artery arteries in animal experiments.
开发显微血管造影系统,以在临床环境中可视化小脑穿支动脉,并在动物实验中可视化球后眼动脉。
- 批准号:
23390305 - 财政年份:2011
- 资助金额:
$ 72.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The study for the modification of cerebral synapses by balance exercises in the elderly based on animal experiments.
基于动物实验的老年人平衡运动改变大脑突触的研究。
- 批准号:
21500471 - 财政年份:2009
- 资助金额:
$ 72.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




